Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance

The use of immune checkpoint inhibitors (ICI) in treating cancer has revolutionized the approach to eradicate cancer cells by reactivating immune responses. However, only a subset of patients benefits from this treatment; the majority remains unresponsive or develops resistance to ICI therapy. Incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Chao-Yuan, Kao, Cheng-Xiang, Chang, Te-Sheng, Huang, Yen-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865434/
https://www.ncbi.nlm.nih.gov/pubmed/33514004
http://dx.doi.org/10.3390/ijms22031258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865434/
https://www.ncbi.nlm.nih.gov/pubmed/33514004
http://dx.doi.org/10.3390/ijms22031258

Ejemplares similares